The world needs a global plan to tackle antimicrobial resistance. Alongside a $2B fund to jump-start innovation there should be a $1B reward for companies when a new antibiotic is launched, says Jim O’Neill, chair of the review
As the first World Antibiotics Awareness week has highlighted, the traditional business model for antibiotics is broken. Incentives are required to promote development of new products, says Luke Moore. What about a lump sum payment?